Century Sage Scientific Holdings Ltd (HK:1450)
:1450
Top Page
Century Sage Scientific Holdings Ltd
(1450)
Select Model
Select Model
Rating:64Neutral
Price Target:
HK$0.96
▼(-15.53% Downside)
Action:ReiteratedDate:11/26/25
The overall stock score of 64 reflects strong technical momentum and a solid financial position, despite challenges in cash flow and valuation concerns. The absence of earnings call data and corporate events means these factors did not influence the score.
Positive Factors
High gross margin & reported revenue increase
A near-48% gross margin plus management's reported revenue expansion indicate durable product-level profitability and pricing power. High gross margins support R&D and commercialization spending, enabling sustainable investment in new diagnostics and devices without immediate margin dilution.
Negative Factors
Weak operating and free cash flow
Zero operating and free cash flow in 2024 signals a structural cash-generation shortfall that impairs the company’s ability to self-fund growth, R&D and capex. Persistent weak cash conversion can force reliance on external financing, increasing cost and execution risk over months.
Read all positive and negative factors
Positive Factors
Negative Factors
High gross margin & reported revenue increase
A near-48% gross margin plus management's reported revenue expansion indicate durable product-level profitability and pricing power. High gross margins support R&D and commercialization spending, enabling sustainable investment in new diagnostics and devices without immediate margin dilution.
Read all positive factors
Century Sage Scientific Holdings Ltd (1450) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$1.10B
Dividend YieldN/A
Average Volume (3M)1.96M
Price to Earnings (P/E)15.9
Beta (1Y)0.40
Revenue Growth-1.52%
EPS Growth-67.16%
CountryHK
Employees1,163
SectorTechnology
Sector Strength88
IndustrySoftware - Application
Share Statistics
EPS (TTM)0.03
Shares Outstanding1,407,203,100
10 Day Avg. Volume2,198,140
30 Day Avg. Volume1,964,156
Financial Highlights & Ratios
PEG Ratio-0.57
Price to Book (P/B)3.34
Price to Sales (P/S)1.12
P/FCF Ratio-30.59
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.24
Revenue Forecast (FY)HK$2.33B
Century Sage Scientific Holdings Ltd Business Overview & Revenue Model
Company Description
Be Friends Holding Ltd. is an investment company, which engages in the provision of hardware and software all-media application solutions. It operates through the following business segments: New Media Services, Application Solutions, System Maint...
How the Company Makes Money
Century Sage Scientific Holdings Ltd generates revenue through multiple streams, primarily by selling its proprietary medical devices and diagnostic products to hospitals, clinics, and healthcare professionals. The company also engages in research...
Century Sage Scientific Holdings Ltd Financial Statement Overview
Summary
Income Statement
65
Positive
Balance Sheet
70
Positive
Cash Flow
50
Neutral
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.25B | 1.25B | 1.07B | 425.61M | 202.79M | 153.31M |
| Gross Profit | 549.39M | 599.30M | 566.91M | 189.80M | 60.33M | 55.85M |
| EBITDA | 90.77M | 119.87M | 184.30M | 19.76M | -22.52M | -44.96M |
| Net Income | 54.00M | 81.71M | 119.46M | -9.21M | -61.62M | -97.53M |
Balance Sheet | ||||||
| Total Assets | 1.01B | 923.92M | 754.59M | 446.91M | 422.68M | 498.64M |
| Cash, Cash Equivalents and Short-Term Investments | 235.59M | 113.32M | 149.54M | 50.93M | 111.06M | 12.78M |
| Total Debt | 51.70M | 252.83M | 168.96M | 151.23M | 182.62M | 182.12M |
| Total Liabilities | 522.86M | 510.21M | 452.88M | 343.92M | 334.29M | 392.86M |
| Stockholders Equity | 493.30M | 418.99M | 297.51M | 93.30M | 65.80M | 80.88M |
Cash Flow | ||||||
| Free Cash Flow | 80.73M | -45.69M | 167.14M | -6.90M | 7.43M | -2.52M |
| Operating Cash Flow | 90.66M | -27.58M | 182.99M | -2.08M | 7.81M | -1.61M |
| Investing Cash Flow | -23.23M | -58.44M | -74.47M | 32.34M | 4.28M | -3.18M |
| Financing Cash Flow | -35.38M | 52.47M | -10.28M | -34.83M | 36.10M | 5.00M |
Century Sage Scientific Holdings Ltd Technical Analysis
Negative
1.14
Price Trends
0.88
Negative
1.01
Negative
1.02
Negative
Market Momentum
-0.03
Negative
36.04
Neutral
32.48
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1450, the sentiment is Negative. The current price of 1.14 is above the 20-day moving average (MA) of 0.81, above the 50-day MA of 0.88, and above the 200-day MA of 1.02, indicating a bearish trend. The MACD of -0.03 indicates Negative momentum. The RSI at 36.04 is Neutral, neither overbought nor oversold. The STOCH value of 32.48 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:1450.
Century Sage Scientific Holdings Ltd Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
64 Neutral | HK$1.10B | 15.88 | 11.84% | ― | -1.52% | -67.16% | |
62 Neutral | HK$587.73M | 4.33 | 32.68% | ― | 421.56% | 328.43% | |
62 Neutral | HK$2.25B | 28.97 | 8.35% | ― | 12.46% | ― | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
52 Neutral | HK$3.94B | 24.36 | -8.12% | ― | 3.97% | -211.11% | |
52 Neutral | HK$5.46B | 55.03 | 6.30% | 3.47% | -17.90% | 56.67% | |
52 Neutral | HK$3.02B | -44.85 | -29.14% | ― | -16.86% | -7.51% |
* Technology Sector Average
HK:1450
Century Sage Scientific Holdings Ltd
0.78
0.00
0.00%
HK:8083
China Youzan
0.12
0.04
46.34%
HK:1675
AsiaInfo Technologies Limited
5.81
-0.75
-11.42%
HK:1808
Enterprise Development Holdings Limited
2.40
-1.30
-35.14%
HK:1588
Chanjet Information Technology Co., Ltd. Class H
6.92
1.34
24.01%
HK:1782
Vixtel Technologies Holdings Ltd.
3.78
-0.71
-15.81%
Century Sage Scientific Holdings Ltd Corporate Events
Be Friends Holding Reshapes Leadership as Li Liang Succeeds Li Jun as Chairman
Jan 27, 2026
Be Friends Holding Limited has announced a leadership reshuffle effective 27 January 2026, with current chairman and executive director Li Jun stepping down from the chairmanship while remaining on the board to focus on driving the group’s i...
Be Friends Holding Announces Board Composition and Committee Roles
Jan 27, 2026
Be Friends Holding Limited, a Cayman Islands–incorporated company listed on the Hong Kong Stock Exchange under stock code 1450, has announced the current composition of its board of directors and the allocation of roles across its key govern...
Be Friends Holding Posts Higher GMV for Q4 and Full Year 2025
Jan 14, 2026
Be Friends Holding Limited reported that its gross merchandise volume (GMV) reached approximately RMB6.49 billion in the fourth quarter of 2025, up around 4.34% from the same period in 2024. For the full year 2025, cumulative GMV totaled about RMB...
Be Friends Holding Limited Passes Key Resolution at EGM
Nov 7, 2025
Be Friends Holding Limited, a company incorporated in the Cayman Islands, announced the successful passage of an ordinary resolution at its Extraordinary General Meeting held on 7 November 2025. The resolution, which involved the ratification and ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.